Menu

Probing Down Syndrome with Mini Brains

Researchers create cerebral organoids using induced pluripotent stem cells from patient skin cells and characterize protein-expression changes linked to cognitive impairment.

Oct 20, 2015
Bob Grant

WIKIMEDIA, NATIONAL HUMAN GENOME RESEARCH INSTITUTEInduced pluripotent stem cells (iPSCs) grown from the skin cells of a person with Down syndrome are helping researchers grow cerebral organoids and track protein expression in an effort to better understand the disorder on a cellular and molecular level. University of Colorado Boulder postdoc Tristan McClure-Begley and his colleagues sought to better understand the neurological and developmental changes that occur in people with a third copy of chromosome 21, the unifying pathological feature of Down syndrome. “That third copy of chromosome 21 influences all aspects of embryonic development, including critical steps during brain development,” McClure-Begley said in a statement. “But we’ve had trouble identifying exactly why the extra chromosome has such widespread effects, partly because we’ve lacked good human tissue models of Down syndrome.”

So McClure-Begley and his colleagues took a fibroblast from a single Down syndrome patient, coaxed it into becoming two iPSC lines, and then reprogrammed those cells into neural progenitor cells that self-organized into cerebral tissue in vitro. “So we get a window into what an individual central nervous system development looked like from a cellular and molecular level,” he said during a Monday (October 19) press conference at the Society for Neuroscience (SfN) annual meeting held in Chicago.

The researchers found that protein expression did not follow a simple 1:1 ratio with the extra genes on the triplicate chromosome 21 leading to a proportional increase in proteins expressed. “Rather, there’s a complex change, where some proteins are upregulated, some proteins are downregulated—all reflecting a general disturbance in signaling,” McClure-Begley said. Many of the perturbed proteins were involved in early neurogenesis and cell cycle regulation, among other functions.

Earlier this year, researchers in Germany reported similar success growing cerebral organoids from iPSCs derived from skin cells of people with autism.

McClure-Begley added that his group plans to generate as many organoids from Down syndrome patients as possible in order characterize protein-expression profiles across the spectrum of the disorder, from mild to severe. “We can start observing . . . the discrete factors in their genome not on chromosome 21 that can influence the severity of their clinical presentation of Down syndrome,” he said. “By doing that, it’s our hope that we will actually be capable of then correlating clinical severity with a molecular signature from these tissues, thereby informing our ability to come up with tailored, personalized treatments to improve quality of life.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!